fosfomycin sodium
Drug ingredientCAS 26016-99-9
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
3 FDA-registered drug labelers
Ercros SA
Meitheal Pharmaceuticals Inc.
MSN Organics Private Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Contepo
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS26016-99-9
PubChem CID73491
DTXSIDDTXSID401017220
FormulaC3H5Na2O4P
Mol. Weight182.02 g/mol
SMILESCC1C(O1)P(=O)([O-])[O-].[Na+].[Na+]
Data Sources
- PubChem · compound 73491Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
fosfomycin sodium (CAS 26016-99-9) https://chemicalindependence.com/chemical/26016-99-9/ PubChem: 73491. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/73491 FDA National Drug Code directory: CAS 26016-99-9. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/